Skip to main content
FinSpry Logo
FinSpry
DAWN logo
DAWN
(NASDAQ)
Day One Biopharmaceuticals, Inc.
$21.45-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Day One Biopharmaceuticals (DAWN) Stock Price & Financial Analysis

Day One Biopharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$21.42 - $21.47
52-Week High$21.46
52-Week Low$5.64
Open$21.43
Volume1.40M
Average Volume (3M)1.40M
Market Cap2.22B
Shares Outstanding103.38M
Price to Sales (P/S)14.00
Price to Book (P/B)5.02
EV/EBITDA-16.82
Revenue (TTM)158.18M
Net Income (TTM)-107.32M
Free Cash Flow (TTM)-111.08M
EPS (TTM)$-1.04
Profit Margin-67.85%
Operating Margin-80.76%
Return on Equity (ROE)-24.33%
Debt to Equity0.01
50-Day MA$15.23
200-Day MA$9.60
52-Week Change181.47%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Day One Biopharmaceuticals

What is the current stock price for DAWN?

As of the latest trading session, DAWN stock trades at $21.45. The 52-week range is $5.64–$21.46, with a day range of $21.42–$21.47.

What is the P/E ratio for DAWN?

The P/E ratio (Price-to-Earnings) for DAWN is shown in the Key Statistics section. This valuation metric helps compare Day One Biopharmaceuticals, Inc. to industry peers.

Does DAWN pay dividends?

Day One Biopharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DAWN?

Based on 10 analysts, the consensus for DAWN is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of DAWN?

Day One Biopharmaceuticals's market capitalization is $2.22B, classifying it as a mid-cap company. Day One Biopharmaceuticals operates in the Healthcare sector within the Biotechnology industry.